The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 65, Issue 1, 2004, Pages 21-28

  Farvid, Maryam Sadat ^a   Siassi, Fereydoun ^a   Jalali, Mahmoud ^a   Hosseini, Mostafa ^a   Saadat, Navid ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apo; apolipoprotein; BMI; body mass index; cardiovascular disease; Cr; creatinine; CVD; HDL c; high density lipoprotein cholesterol; LDL c; lipid standardized tocopherol; low density lipoprotein cholesterol; LS TOH; M; magnesium; Mg; mineral; MV

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; TRIACYLGLYCEROL; ZINC;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MINERAL BLOOD LEVEL; MINERAL INTAKE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ASCORBIC ACID; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EATING; FEMALE; HUMANS; INTERVIEWS; LIPIDS; MAGNESIUM; MALE; MIDDLE AGED; TRIGLYCERIDES; VITAMIN E; ZINC;

EID: 2442555702     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.11.009     Document Type: Article

References (43)

1. King G.L., Kunisaki M., Nishio Y., Inoguchi T., Shiba T., Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes. 45:1996;S105-S108
2. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267
3. Rosen P., Du X., Tschope D. Role of oxygen-derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol. Cell Biochem. 188:1998;103-111
4. Assmann G., Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am. Heart J. 116:1988;1713-1724
5. Haffner S.M. Management of dyslipidemia in adults with diabetes. Diabetes Care. 21:1998;160-178
6. Bodzek P., Wielkoszynski T., Zamlynski J., Koziol M., Manka G., Strojek K. The estimation of L-ascorbic acid serum concentration and selected parameters of metabolism of serum lipids in pregnant women with diabetes. Ginekol. Pol. 70:1999;667-671
7. Singh R.B., Niaz M.A., Rastogi S.S., Bajaj S., Gaoli Z., Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of north India. J. Am. Coll. Nutr. 17:1998;564-570
8. Djurhuus M.S., Henriksen J.B., Klitgaard N.A., et al. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care. 22:1999;546-554
9. Simon J.A., Hudes E.S. Relation of serum ascorbic acid to serum lipids and lipoproteins in US adults. J. Am. Coll. Nutr. 17:1998;250-255
10. Guerrero-Romero F., Rodriguez-Morán M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J. Diabetes Complications. 14:2000;272-276
11. Jain S.K., McVie R., Jaramillo J.J., et al. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids. 31:1996;S87-S90
12. Tofler G.H., Stec J.J., Stubbe I., et al. The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjects. Thrombosis Res. 100:2000;35-41
13. Paolisso G., Balbi V., Volpe C., et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J. Am. Coll. Nutr. 14:1995;387-392
14. Miller E.R. III, Appel L.J., Levander O.A., Levine D.M. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J. Cardiovasc. Risk. 4:1997;19-24
15. Gomez-Perez F.J., Valles-Sanchez V.E., Lopez-Alvarenga J.C., et al. Vitamin E modifies neither froctosamine nor HbA1c levels in poorly controlled diabetes. Rev. Invest. Clin. 48:1996;421-424
16. Eibl N.L., Kopp H.P., Nowak H.R., Schnack C.J., Hopmeier P.G., Schernthaner G. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care. 18:1995;188-192
17. Eriksson J., Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann. Nutr. Metab. 39:1995;217-223
18. de Valk H.W., Verkaaik R., van Rijn H.J.M., Geerdink R.A., Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabetes Med. 15:1998;503-507
19. Djurhuus M.S., Klitgaard N.A.H., Pedersen K.K., et al. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism. 50:2001;1409-1417
20. Itoh K., Kawasaki T., Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br. J. Nutr. 78:1997;737-750
21. Hamilton I.M.J., Gilmore W.S., Benzie I.F.F., Mulholland C.W., Strain J.J. Interactions between vitamin C and E in human subjects. Br. J. Nutr. 84:2000;261-267
22. Zago M.P., Oteiza P.I. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic. Biol. Med. 31:2001;266-274
23. Meydani S.N., Meydani M., Rall L.C., Morrow F., Blumberg J.B. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am. J. Clin. Nutr. 60:1994;704-709
24. Barbagallo M., Dominguez L.J., Tagliamonte M.R., Resnick L.M., Paolisso G. Effects of vitamin E and glutathione on glucose metabolism, role of magnesium. Hypertension. 34:1999;1002-1006
25. Paolisso G., Tagliamonte M.R., Barbieri M., et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 85:2000;109-115
26. J.H. Roe, Ascorbic acid, in: P. Gyorgy, W.N. Pearson (Eds.), The Vitamins, Academic Press, New York, 1967, pp. 27-51.
27. Sanz D.C., Santa-Cruz M.C. Simultaneous measurement of retinol and α-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 380:1986;140-144
28. Homsher R., Zak B. Spectrophotometric investigation of sensitive complexing agents for the determination of zinc in serum. Clin. Chem. 31:1985;1310-1313
29. Barbour H.M., Davidson W. Studies on measurement of plasma magnesium application of Magon dye method to the Monarch centrifugal analyzer. Clin. Chem. 34:1988;2103-2105
30. Stol C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand. J. Clin. Lab. Invest. 17:1965;381-387
31. McNamara J.R., Cohn J.S., Wilson P.W., Schaefer E.J. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin. Chem. 36:1990;36-42
32. Okada M., Matsui H., Ito Y., Fujiwara A., Inano K. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J. Lab. Clin. Med. 132:1998;195-201
33. Boden W.E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86:2000;19L-22L
34. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 79:1989;8-15
35. Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. The Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. New Engl. J. Med. 341:1999;410-418
36. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced inhibition of plasma lipoprotein lipid peroxidation. Free Radic. Biol. Med. 22:1997;57-71
37. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1646-1650
38. Anderson R.A., Roussel A.M., Zouari N., Mahjoub S., Matheau J.M., Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J. Am. Coll. Nutr. 20:2001;212-218
39. Kajanachumpol S., Srisurapanon S., Supanit I., Roongpisuthipong C., Apibal S. Effect of zinc supplementation on zinc status, copper status and cellular immunity in elderly patients with diabetes mellitus. J. Med. Assoc. Thai. 78:1995;344-349
40. Bussiere L., Mazur A., Gueux E., Nowacki W., Rayssiguier Y. Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. Magnes. Res. 8:1995;151-157
41. Zhou Q., Mahfouz M.M., Kummerow F.A. Effect of dietary magnesium deficiency with/without cholesterol supplementation on phospholipid content in liver, plasma, and erythrocytes of rabbits. Magnes. Res. 7:1994;23-30
42. Nadler J.L., Malayan S., Luong H., Shaw S., Natarajan R.D., Rude R.K. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care. 15:1992;835-841
43. American Diabetes Association, Magnesium supplementation in the treatment of diabetes, Diabetes Care 15 (1992) 1065-1067.